FDA 21 CFR Part 11 Compliance in Life Sciences for 2025
In 2025, the life sciences industry continues to advance at a remarkable pace, driven largely by digital transformation.
Article
GMP compliance in life sciences with next-gen tech
Life sciences companies face mounting pressure to meet stringent FDA and EMA manufacturing standards without compromising compliance. Next-gen tech in the form of B2B SaaS compliance solutions is helping pharmaceutical companies to maintain regulatory approval and make strategic advancements.
Article